ibusinesslines.com December 09, 2018

FDA Approves 1st Home Test for Breast Cancer Genes

07 March 2018, 04:15 | Melissa Porter

A 23and Me kit Lydia Ramsey Business Insider

23andMe kit

The newly authorized test identifies three of 1000-plus mutations associated with breast cancer risk. No doctor's prescription will be needed for the test. These three mutations, however, are not the most common BRCA1/BRCA2 mutations in the general population.

The test is fairly straightforward.

The test analyzes DNA collected from a self-collected saliva sample, and the report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer.

So, while it is unclear what policy shift caused the FDA's recent change of heart, the announcement it published is jam-packed with caveats, highlighting the limitations of 23andme's now approved DTC test.

"The test only detects three out of more than 1,000 known BRCA mutations".

Of course, the test shouldn't be taken as the be all, end all of cancer risk - nor is it meant as a replacement for a proper screening.

"This test provides information to certain individuals who may be at increased breast, ovarian or prostate cancer risk and who might not otherwise get genetic screening, and is a step forward in the availability of [direct-to-consumer] genetic tests".

The approval comes four years after the FDA threw the brakes on 23andMe's race across the consumer genetic testing landscape in a November 2013 warning letter that amounted to a cease-and-desist order.

Around one in 400 people have BRCA mutations that can cause cancer, and is more common among those with eastern European or Jewish descent. The American Cancer Society says this year, it will be diagnosed in 260,000 women and a few men, and will kill almost 41,000.

The FDA today granted authorization for a direct-to-consumer test for a highly selected group of cancer-associated BRCA mutations.

According to the National Cancer Institute, the three mutations are present in ~2% of Ashkenazi Jewish women compared to 0 - 0.1% in other populations.

"For some people who might be getting this test, it might be hard for people to interpret and understand those results".

The FDA says the test is not a substitute for regular medical checkups and should not be used to make any medical decisions. The agency also outlined special controls created to assure test's accuracy and reliability.

Other News

Trending Now

Suffolk's Bill Turnbull opens up about cancer battle on Celebrity Bake Off
He said: "The GP said, "It's clear you have prostate cancer and that it's spread to the bone". The star, 60, had his prostate removed in January after being diagnosed in December.

Lil' Kim Walks Out With Deontay Wilder While Performing 'Spicy'
Add to that he carries his power throughout the fight and isn't afraid to let his hands go when the result is on the line. In the fifth, with boos raining down from the crowd of 14,069 at Barclays Center, Wilder finally landed a solid punch.

The 2019 McLaren Senna GTR is the Quickest McLaren Outside Formula 1
Unlike the road-legal McLaren Senna , the McLaren Senna GTR will feature a polycarbonate "ticket" window. New on the Senna GTR are the wider front and rear fenders which allow the vehicle to have a wider track.

Coinbase Announces Launch of Crypto Index Fund - Not Ripple Addition
The company also introduced Coinbase Index , which measures the financial performance of all the Coinbase-listed currencies. The new fund will allow USA customers to invest in the cryptocurrencies Coinbase now lists as a whole.

South Korean politician steps down after rape accusations
Kim mentioned the abuse of power that took place in Ahn's office and how it was complicated for her to reject her boss's requests. Hours later, he announced his resignation as governor of South Chungcheong Province and retirement from public life.

State of Decay 2 gets May 22 release date
Now, we have a final release date, as well as pricing information, which is much cheaper than we were expecting. They want to foster even deeper experiences with the franchise so it may grow to become an even bigger title.

OPEC to Meet With Hedge Funds' Representatives on CERAweek Sidelines in Houston
Doing so would mean handicapping themselves and ceding even more market share to US shale and other non-OPEC producers. A decision on extending the production limits beyond this year will be made at meetings in June and November, he said.